Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population
详细信息 查看全文
- 作者：Wani Arjumand (1)
Shiekh Tanveer Ahmad (1)
Amlesh Seth (2)
Ashish Kumar Saini (2)
Sarwat Sultana (1) - 关键词：VDR gene ; FokI ; BsmI ; Single nucleotide polymorphism ; RCC
- 刊名：Tumor Biology
- 出版年：2012
- 出版时间：February 2012
- 年：2012
- 卷：33
- 期：1
- 页码：23-31
- 全文大小：154KB
- 参考文献：1. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin d receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30:1170. CrossRef
2. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684-00. CrossRef
3. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin d receptor gene variants. Epidemiol Rev. 2000;22:203.
4. Ntais C, Polycarpou A, Ioannidis J. Vitamin d receptor gene polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:1395.
5. K?stner KIM, Denzer N, Müller CSL, Klein R, Tilgen W, Reichrath J. The relevance of vitamin d receptor (vdr) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511.
6. Saijo T, Ito M, Takeda E, Huq AH, Naito E, Yokota I, et al. A unique mutation in the vitamin d receptor gene in three japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet. 1991;49:668.
7. Arai H, Miyamoto KI, Taketani Y, Yamamoto H, Iemori Y, Morita K, et al. A vitamin d receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997;12:915-1. CrossRef
8. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, et al. The polymorphic n terminus in human vitamin d receptor isoforms influences transcriptional activity by modulating interaction with transcription factor iib. Mol Endocrinol. 2000;14:401. CrossRef
9. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR. Molecular nature of the vitamin d receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001;2:203-6. CrossRef
10. MacLaughlin JA, Anderson RR, Holick MF. Spectral character of sunlight modulates photosynthesis of previtamin d3 and its photoisomers in human skin. Science. 1982;216:1001. CrossRef
11. Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP, van Leeuwen JPTM. Genetics and biology of vitamin d receptor polymorphisms. Gene. 2004;338:143-6. CrossRef
12. Trump DL, Hershberger PA, Bernardi RJ, Ahmed S, Muindi J, Fakih M, et al. Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J Steroid Bochem Mol Biol. 2004;89:519-6. CrossRef
13. Ordonez-Moran P, Larriba MJ, Pendas-Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci. 2005;10:2723-9. CrossRef
14. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 2006;371:1-2. CrossRef
15. Hino O, Kobayashi T, Momose S, Kikuchi Y, Adachi H, Okimoto K. Renal carcinogenesis: genotype, phenotype and dramatype. Cancer Sci. 2003;94:142-. CrossRef
16. Slattery ML, Vitamin D. receptor gene (VDR) associations with cancer. Nutr Rev. 2007;65:S102-. CrossRef
17. Ikuyama T, Hamasaki T, Inatomi H, Katoh T, Muratani T, Matsumoto T. Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese. Endocr J. 2002;49:433. CrossRef
18. Fujioka T, Suzuki Y, Okamoto T, Mastushita N, Hasegawa M, Omori S. Prevention of renal cell carcinoma by active vitamin D3. World J Surg. 2000;24:1205-0. CrossRef
19. Madej A, Puzianowska-Kuznicka M, Tanski Z, Nauman J, Nauman A. Vitamin D receptor binding to DNA is altered without the change in its expression in human renal clear cell cancer. Nephron Exp Nephrol. 2000;93:150-. CrossRef
20. Harris LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione / S-transferase pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18:641. CrossRef
21. Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the united states. JAMA. 1999;281:1628. CrossRef
22. Mathew A, Devesa SS, Fraumeni Jr JF, Chow WH. Global increases in kidney cancer incidence, 1973-992. Eur J Cancer Prev. 2002;11:171. CrossRef
23. Obara W, Suzuki Y, Kato K, Tanji S, Konda R, Fujioka T. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a japanese population. Int J Urol. 2007;14:483-. CrossRef
24. Karami S, Brennan P, Hung RJ, Boffetta P, Toro J, Wilson RT, et al. Vitamin d receptor polymorphisms and renal cancer risk in central and eastern europe. J Toxicol Environ Health, Part A. 2008;71:367-2. CrossRef
25. Jafar T, Tripathi G, Mehndi AA, Mandal K, Gulati S, Sharma RK, et al. Vitamin D receptor gene polymorphisms in indian children with idiopathic nephrotic syndrome. Int J Hum Genet. 2009;9:49-5.
26. Mittal RD, Mishra DK, Srivastava P, Manchanda P, Bid HK, Kapoor R. Polymorphisms in the vitamin d receptor and the androgen receptor gene associated with the risk of urolithiasis. Indian J Clin Biochem. 25:119-6.
27. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism (s) and breast cancer risk in north indians. Cancer Detect Prevent. 2009;32:386-4. CrossRef
28. Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer. 1998;77:1508. CrossRef
29. Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol. 1999;149:521.
30. Bj?rge T, Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol. 2004;160:1168. CrossRef
31. Zhao X, Feldman D. Regulation of vitamin d receptor abundance and responsiveness during differentiation of ht-29 human colon cancer cells. Endocrinology. 1993;132:1808. CrossRef
32. Tripathi G, Sharma R, Sharma RK, Gupta SK, Sankhwar SN, Agrawal S. Vitamin D receptor genetic variants among patients with end-stage renal disease. Renal Fail. 32:969-7.
33. Israni N, Goswami R, Kumar A, Rani R. Interaction of vitamin D receptor with hla drb1* 0301 in type 1 diabetes patients from north india. PLoS One. 2009;4:e8023. CrossRef
34. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, et al. Vitamin D receptor (VDR) mrna and vdr protein levels in relation to vitamin d status, insulin secretory capacity, and VDR genotype in bangladeshi asians. Diabetes. 2002;51:2294. CrossRef
35. Filus A, Trzmiel A, Kuliezkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewiez A. Relationship between VDR / BsmI and / FokI polymorphism and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008;11:134-. CrossRef
36. Obara W. Analysis of vitamin d receptor gene polymorphism in human renal cell carcinoma detected by polymerase chain reaction-restriction fragment length polymorphism. J Iwate Med Assoc. 2001;53:191-.
37. Hanahan D. The hallmarks of cancer. Cell. 2000;100:57-0. CrossRef
38. Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. 1,25-Dihydroxyvitamin D3 (calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther. 2007;6:1433-. CrossRef
39. Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, Murai M. Renal cancer cells lacking hypoxia inducible factor (hif)-1alpha expression maintain vascular endothelial growth factor expression through hif-2alpha. Carcinogenesis. 2007;28:529-6. CrossRef - 作者单位：Wani Arjumand (1)
Shiekh Tanveer Ahmad (1)
Amlesh Seth (2)
Ashish Kumar Saini (2)
Sarwat Sultana (1)
1. Section of Molecular Carcinogenesis and Chemoprevention, Department of Medical Elementology and Toxicology, Faculty of Science, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, 110062, India
2. Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India - ISSN：1423-0380
文摘
Vitamin D exerts its activity through binding to the high-affinity nuclear vitamin D receptor (VDR), and majority of genetic studies have primarily focused on variation within this gene. Therefore, analysis of genetic variation in VDR genes may provide insight into the role of vitamin D in renal cell carcinoma (RCC) etiology in our study population. This study investigated whether VDR gene polymorphisms were associated with increased risk and prognosis of RCC in the North Indian population. Genotyping of two polymorphic sites (FokI and BsmI) in the VDR gene of 196 RCC cases and 250 healthy controls was performed via PCR-RFLP. The frequency of homozygous genotype FF was 31.6%, heterozygous Ff was 48.0%, and homozygous ff was 20.4% in cases, whereas in controls it was 45.6%, 39.2%, and 15.2%, respectively; thus, there was a significant difference between the two groups (p Trend--.011) in the univariate model. The frequencies of the BB, Bb, and bb genotypes were 25.5%, 44.9% and 29.6% in cases, respectively, while in controls it was 33.2%, 52.0% and 14.8%, respectively; thus, there was a significant difference between the two groups (p Trend--.001) in the univariate model. The two high-risk genotype ff of FokI and bb of BsmI of VDR showed a cumulative 1.87-fold increase in risk to RCC. Moreover, the FF genotype was associated with lower pathological stage and histological grade. Our results suggest that the FokI and BsmI genotypes of VDR gene may be implicated in the pathogenesis of RCC.